Evidence map›Paper›PMID 40520814›Full record

ArticleJHLT open2025

Outcomes with venoarterial vs venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation in interstitial lung disease.

Prasanth Balasubramanian, Pablo Moreno Franco, Sanjay Chaudhary, Francisco G Alvarez, Maher Baz, Tathagat Narula, Sadia Z Shah, Mohammad Alomari, Rohan Bongu, Anirban Bhattacharrya and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Prasanth BalasubramanianDivision of Lung Failure and Transplant, Department of Transplantation, Mayo Clinic, Jacksonville, Florida.
Pablo Moreno FrancoDepartment of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, Florida.
Sanjay ChaudharyDepartment of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, Florida.
Francisco G AlvarezDivision of Lung Failure and Transplant, Department of Transplantation, Mayo Clinic, Jacksonville, Florida.
Maher BazDivision of Lung Failure and Transplant, Department of Transplantation, Mayo Clinic, Jacksonville, Florida.
Tathagat NarulaDivision of Lung Failure and Transplant, Department of Transplantation, Mayo Clinic, Jacksonville, Florida.
Sadia Z ShahDivision of Lung Failure and Transplant, Department of Transplantation, Mayo Clinic, Jacksonville, Florida.
Mohammad AlomariDepartment of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, Florida.
Rohan BonguDivision of Lung Failure and Transplant, Department of Transplantation, Mayo Clinic, Jacksonville, Florida.
Anirban BhattacharryaDepartment of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida.
Devang SanghaviDepartment of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida.
Sean KileyDepartment of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida.
Archer K MartinDivision of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesia and Peri-op Medicine, Mayo Clinic, Jacksonville, Florida.
Nikki L MatosDepartment of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida.
John C HaneyDepartment of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, Florida.
Ian MakeyDepartment of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, Florida.
Mathew ThomasDepartment of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, Florida.
Pramod K GuruDepartment of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida.
Remzi BagDivision of Lung Failure and Transplant, Department of Transplantation, Mayo Clinic, Jacksonville, Florida.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evidence on outcomes associated with venoarterial (VA) versus venovenous (VV) of extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation (LTx) in interstitial lung disease (ILD) is limited. Methods: Using the United Network for Organ Sharing (UNOS) Standard Transplant Analysis and Research (STAR) registry, we conducted a retrospective cohort study on ILD patients bridged with ECMO for LTx. Outcomes by cannulation type (VV vs VA) were analyzed, with 1:1 propensity matching to reduce selection bias. Results: Among 1,551 patients, 1,236 (79.7%) were on VV ECMO and 315 (20.3%) on VA ECMO. Delisting due to death or deterioration was higher with VA ECMO in both the overall (41% vs 27%, Conclusions: VV ECMO was associated with a more successful bridge to LTx than VA ECMO. Adjusted post-transplant outcomes were comparable. Prospective studies are warranted to explore outcome differences by cannulation strategy in ILD.

Indexed as

cannulationextracorporeal membrane oxygenation (ECMO)interstitial lung disease (ILD)lung transplantationpulmonary hypertension

Identifiers

PMID40520814
PMCPMC12166393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.